|
|
||||||||
The Journal of Immunology, Vol 156, Issue 12 4617-4621, Copyright © 1996 by American Association of Immunologists
ARTICLES |
J Marcinkiewicz, A Grabowska and BM Chain
Department of Immunology, College of Medicine, Jagiellonian University, Cracow, Poland.
Nitric oxide (NO) can have both effector (cytotoxic) and regulatory roles in immune function. In this study, we have re-examined the potential role of nitric oxide in mediating the macrophage-dependent suppression of IL-2 synthesis. In our model, TNP-specific CD4+ T cells are cocultured with Ag and either peritoneal or alveolar macrophages. Both populations of macrophages after in vitro stimulation with IFN- gamma can inhibit IL-2 release. In vitro stimulation also induces substantial levels of NO release by these macrophages, as well as high levels of prostaglandin E2 (PGE2). However, there was no correlation between NO levels and inhibitory activity. Furthermore, NG-monomethyl-L- arginine monoacetate, a specific inhibitor of NO release had no effect on IL-2 release, while indomethacin, which blocked prostaglandin synthesis, largely abrogated the suppressor activity of both macrophage populations. Although the addition of exogenous NO donors at high concentrations could inhibit IL-2 release by T cells, our data does not support the hypothesis that NO is a major macrophage mediator of suppression in this model.
This article has been cited by other articles:
![]() |
O. Kosonen, H. Kankaanranta, M. Lähde, P. Vuorinen, P. Ylitalo, and E. Moilanen Nitric Oxide-Releasing Oxatriazole Derivatives Inhibit Human Lymphocyte Proliferation by a Cyclic GMP-Independent Mechanism J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 215 - 220. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |